Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating Agents

NCT03276910 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Sports Drug Abuse

Interventions

DRUG: EPREX
DRUG: sodium chloride AGUETTANT 0.9%

Sponsor

Association Athletes For Transparency

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]